1. Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!

   • Poul Flemming Høilund-Carlsen
   • Søren Hess
   • Abass Alavi

   Editorial Open access 21 February 2018 Pages: 893 - 897

   

2. Imaging α_vβ₃ integrin expression in skeletal metastases with ^99mTc-maraciclatide single-photon emission computed tomography: detection and therapy response assessment

   • Gary J. R. Cook
   • Gurdip K. Azad
   • Vicky Goh

   Original Article Open access 02 February 2018 Pages: 898 - 903

   

3. ⁶⁸Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer

   • Christos Sachpekidis
   • P. Bäumer
   • A. Dimitrakopoulou-Strauss

   Original Article 23 January 2018 Pages: 904 - 912

   

4. PSA-stratified detection rates for [⁶⁸Ga]THP-PSMA, a novel probe for rapid kit-based ⁶⁸Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer

   • Thorsten Derlin
   • Sebastian Schmuck
   • Frank M. Bengel

   Original Article 07 January 2018 Pages: 913 - 922

   

5. Investigation of receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index

   • Silvia Nicolini
   • Stefano Severi
   • Giovanni Paganelli

   Original Article 01 February 2018 Pages: 923 - 930

   

6. Ultra-early response assessment in lymphoma treatment: [¹⁸F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment

   • Marius E. Mayerhoefer
   • Markus Raderer
   • Alexander Haug

   Original Article Open access 26 February 2018 Pages: 931 - 940

   

7. Assessment of alteration in liver ¹⁸F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score

   • Thibault Salomon
   • Catherine Nganoa
   • Charline Lasnon

   Original Article Open access 26 December 2017 Pages: 941 - 950

   

8. Repeatability of quantitative ¹⁸F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis

   • G. M. Kramer
   • Y. Liu
   • on behalf of the QuIC-ConCePT consortium

   Original Article Open access 23 January 2018 Pages: 951 - 961

   

9. The relationship between local recurrences and distant metastases in prostate cancer: can ¹¹C-choline PET/CT contribute to understand the link?

   • Giampiero Giovacchini
   • Andrea Ciarmiello
   • Maria Picchio

   Original Article 16 February 2018 Pages: 962 - 969

   

10. Prospective observational study of ¹⁷⁷Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

    • Ulrike Garske-Román
    • Mattias Sandström
    • Dan Granberg

    Original Article Open access 01 March 2018 Pages: 970 - 988

    

11. Combined model-based and patient-specific dosimetry for ¹⁸F-DCFPyL, a PSMA-targeted PET agent

    • Donika Plyku
    • Esther Mena
    • Robert F. Hobbs

    Original Article 19 February 2018 Pages: 989 - 998

    

12. Antitumor effects of radionuclide treatment using α-emitting meta-²¹¹At-astato-benzylguanidine in a PC12 pheochromocytoma model

    • Yasuhiro Ohshima
    • Hitomi Sudo
    • Noriko S. Ishioka

    Original Article Open access 19 January 2018 Pages: 999 - 1010

    

13. ¹¹C–acetate PET/CT: a potential alternative of transcranial biopsy for grading cerebral gliomas

    • Jun Hatazawa

    Editorial Commentary Open access 19 February 2018 Pages: 1011 - 1011

14. The roles of ¹¹C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral glioma

    • Soyoung Kim
    • Dongwoo Kim
    • Mijin Yun

    Original Article 06 March 2018 Pages: 1012 - 1020

    

15. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

    • Tharick A. Pascoal
    • Sulantha Mathotaarachchi
    • for the Alzheimer’s Disease Neuroimaging Initiative

    Original Article Open access 02 February 2018 Pages: 1021 - 1030

    

16. Hybrid MR-PET of brain tumours using amino acid PET and chemical exchange saturation transfer MRI

    • N. A. da Silva
    • P. Lohmann
    • N. Jon Shah

    Original Article 24 February 2018 Pages: 1031 - 1040

    

17. A first-in-man PET study of [¹⁸F]PSS232, a fluorinated ABP688 derivative for imaging metabotropic glutamate receptor subtype 5

    • Geoffrey Warnock
    • Michael Sommerauer
    • Simon M. Ametamey

    Original Article 27 November 2017 Pages: 1041 - 1051

    

18. Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [¹²³I]FP-CIT SPECT images

    • Francisco P. M. Oliveira
    • Diogo Borges Faria
    • João Manuel R. S. Tavares

    Original Article 23 December 2017 Pages: 1052 - 1062

    

19. FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance

    • Nils Helsen
    • Tim Van den Wyngaert
    • Sigrid Stroobants

    Review Article 24 February 2018 Pages: 1063 - 1071

    

20. Is it time to change our vision of tumor metabolism prior to immunotherapy?

    • Fabio Grizzi
    • Angelo Castello
    • Egesta Lopci

    Letter to the Editor 12 March 2018 Pages: 1072 - 1075

    

21. Advantage of ¹⁸F-PSMA-1007 over ⁶⁸Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion

    • Kambiz Rahbar
    • Matthias Weckesser
    • Martin Bögemann

    Image of the Month 14 February 2018 Pages: 1076 - 1077

    

22. Correction to: Biological tumour volumes of gliomas in early and standard 20–40 min ¹⁸F-FET PET images differ according to IDH mutation status

    • M. Unterrainer
    • I. Winkelmann
    • N. L. Albert

    Correction 15 March 2018 Pages: 1078 - 1078